Nasonex Nasal Spray Recall

COPD International Your Support Network

		You can learn to control this disease instead of letting it control you!

		Return To The Main Library <<<<>>>> Return To The HomePage

Schering Corp. Recalls Nasonex Nasal Spray

Reason: Defective container.
Distribution: Nationwide.

SafetyAlerts
September 4, 2002

The Food and Drug Administration (FDA) has released the following information.

PRODUCT
Nasonex Nasal Spray (mometasone furoate monohydrate) 50 mcg, Net Contents: 17 g, 120 Metered Sprays, FOR INTRANASAL USE ONLY. Rx only. Recall # D-400-2.

CODE
1-KTL-147 Exp. date 3.03.

RECALLING FIRM/MANUFACTURER
Recalling Firm: Schering Corpration, Kenilworth, NJ, by fax on an unknown date and by letters on August 12, 2002.
Manufacturer: Schering-Plough Products, Inc., Manati, Puerto Rico. Firm initiated recall is ongoing.

REASON
Defective container; missing part in actuator may cause a narrow stream of product to be dispensed rather than a fine spray

VOLUME OF PRODUCT IN COMMERCE
295,620 units.

DISTRIBUTION

Nationwide.